Please use this identifier to cite or link to this item: https://repositorio.ufba.br/handle/ri/16383
metadata.dc.type: Artigo de Periódico
Title: 2D chemometric studies of a series of azole derivatives active against fluconazole-resistant Cryptococcus gattii
Other Titles: Journal of the Brazilian Chemical Society
Authors: Freitas, Humberto F.
Barros, Tânia Fraga
Castilho, Marcelo Santos
metadata.dc.creator: Freitas, Humberto F.
Barros, Tânia Fraga
Castilho, Marcelo Santos
Abstract: Despite advances in the development of antifungal drugs,there has been an upsurge of cryptococosis infections that poorly respond to fluconazole (first choice drug). Hence,it is paramount to investigate the chemical properties of azole derivatives that are active against resistant C. neoformans. In order to achieve this goal,the susceptibility profile of a clinical isolate of resistant C. neoformans against 33 commercial azole derivatives was evaluated along with their potency (minimum inhibitory concentration,MIC). These data were employed to build SIMCA (soft independent modeling of class analogies) models that pinpoint the importance of electronic features (JGI10) to separate active from inactive compounds and hologram-QSAR models that have good fit but insufficient predictive power (HQSAR,r2 = 0.85, q2 = 0.35 and r 2 pred = 0.38). Conversely, 2D QSAR models built from topological descriptors improved the statistical quality (r2 = 0.95, q2 = 0.86, r2 pred = 0.72) and highlight that charge distribution (GGI1) and topological electronegativity (GATS1e and MATS2e) should be modulated to overcome the C. neoformans resistance.
Keywords: Cryptococosis
Azole resistance
2D QSAR
SIMCA
HQSAR
metadata.dc.publisher.country: Brasil
metadata.dc.rights: Acesso Aberto
URI: http://repositorio.ufba.br/ri/handle/ri/16383
Issue Date: 2013
Appears in Collections:Artigo Publicado em Periódico (FAR)

Files in This Item:
File Description SizeFormat 
10.5935-0103-5053.20130122.pdf629,13 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.